News

NIDA releases strategic plan to prevent, treat substance use disorders


 

References

The National Institute on Drug Abuse (NIDA) has developed a 5-year strategic plan aimed at gaining new information about the basic science of the brain as it relates to the causes and consequences of drug use and addiction. Part of the plan is to use novel findings about the brain to create more effective interventions for preventing and treating substance use disorders, according to a written statement by NIDA.

The plan for 2016-2020, which NIDA has named “Advancing Addiction Science,” calls for the achievement of the following four strategic goals:

©moodboard/Thinkstock

• Identify the biological, environmental, behavioral, and social causes and consequences of drug use and addiction across the lifespan.

• Develop improved strategies to prevent drug use and its consequences.

• Develop new and improved treatments to help people with substance use disorders achieve and maintain a meaningful and sustained recovery.

• Increase the public health impact of NIDA research and programs.

“Developing this plan was a collaborative effort incorporating guidance from the National Advisory Council on Drug Abuse, scientific and clinical experts, stakeholder organizations, and the public,” NIDA Director Nora Volkow said in a written statement.

“This plan outlines our broad goals across basic science, prevention, treatment, and public health; identifies four priority focus areas that we believe present unique opportunities to be leveraged over the next 5 years; and reflects a flexible, dynamic approach that will allow us to adapt to new scientific and technological advances and changing public health needs, and to take advantage of scientific opportunities as they arise,” she said.

More information about the plan is available here.

klennon@frontlinemedcom.com

Recommended Reading

U.S. surgeon general to commission first-ever report on addiction
MDedge Internal Medicine
FDA panel cautiously OKs subdermal depot buprenorphine
MDedge Internal Medicine
Increased heroin use may not be linked to rise in prescription opioid use
MDedge Internal Medicine
Clinical Guidelines: USPSTF guidelines for treatment of tobacco dependence (2015)
MDedge Internal Medicine
One clinic at a time: Kentucky doctor works to change opioid prescribing
MDedge Internal Medicine
Practice guideline released for treating opioid use disorder
MDedge Internal Medicine
DEA’s rescheduling of hydrocodone tied to declines in prescribing
MDedge Internal Medicine
Physicians’ odds of beating addiction higher
MDedge Internal Medicine
Lifetime use of pot affects verbal memory in middle-aged adults
MDedge Internal Medicine
FDA announces new plan to combat opioid abuse
MDedge Internal Medicine